Artificial intelligence: Evolving role in drug design

Artificial Intelligence assumes a significant part in drug disclosure. Specifically fake neuralorganizations, for example, profound neural organizations or repetitive organizations drive this region. Various applications in property or action expectations like physicochemical and pharmacokinetic pro...

Ausführliche Beschreibung

Bibliographische Detailangaben

Hauptverfasser:	Dahiya, Akshay, Sharm, Rajiv, Arora, Saahil, Bora, Kundan Singh, Sharma, Ram babu
Format:	Tagungsbericht
Sprache:	eng
Schlagworte:	Artificial intelligence Organizations
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!